Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.12 +0.67 (+12.40%)
As of: Nov 11, 2026 · 1:09 PM EST

Phathom Pharmaceuticals (PHAT) Revenue (2023 - 2026)

Updated

Analysis

Phathom Pharmaceuticals (PHAT) Revenue (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Phathom Pharmaceuticals 442.66 Mn -246.70 Mn 66.36 Mn 84.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 84.72 Mn
Jun 30, 2026 74.27 Mn
Mar 31, 2026 58.30 Mn
Dec 31, 2025 57.58 Mn
Sep 30, 2025 49.50 Mn
Jun 30, 2025 39.50 Mn
Mar 31, 2025 28.52 Mn
Dec 31, 2024 29.66 Mn
Sep 30, 2024 16.35 Mn
Jun 30, 2024 7.32 Mn
Mar 31, 2024 1.91 Mn
Dec 31, 2023 682,000.00
API Access

Phathom Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEY